跳至主要内容
临床试验/NCT07464730
NCT07464730招募中不适用

Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

Region Stockholm1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年4月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Frequency of postoperative pulmonary complications (PPC) the first seven days after high-risk abdominal or non-cardiac thoracic surgery in high-risk patients with high-flow nasal oxygen or conventional oxygen therapy in the immediate postoperative period

研究概览

简要总结

High flow nasal oxygen (HFNO) in the immediate postoperative period has been demonstrated to reduce the risk of postoperative pulmonary complications (PPC) after cardiothoracic surgery. In specific groups of patients such as the obese and after upper abdominal surgery the results are contradictive. However, there is lack of evidence if HFNO in the general high-risk patient after abdominal and non-cardiac thoracic surgery can reduce the prevalence of PPC, hypoxaemia and escalation of therapy. Therefore, the investigators aim to compare the use of HFNO with conventional oxygen therapy (COT) in high-risk patients after abdominal and non-cardiac thoracic surgery regarding postoperative pulmonary complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥18 years old) scheduled for elective abdominal (laparotomy or laparoscopy), open abdominal vascular or non-cardiac thoracic surgery under general anaesthesia with an estimated duration over 3 hours.
  • Meeting at least two of the following criteria:
  • Age > 65 years
  • Preoperative SpO2 <95 %
  • Scheduled for lobectomy or pulmonary segment resection
  • Respiratory tract infection the last month
  • Preoperative anaemia (Hb <100) or severe hypoalbuminemia (<20 g/L)
  • Current smoker or previous smoker with >30 packyears
  • Pulmonary disease or OSAS
  • Heart failure
  • Clinical frailty (CFS 4)

排除标准

  • Not suitable for postoperative HFNO, as decided by a study member or the anaesthetist in charge (such as total nasal obstruction, skull fracture, facial injuries)
  • Pregnancy
  • Not able to understand the study information or sign an informed consent.
  • Not able to participate with the treatment postoperatively
  • Planned for delayed extubation in the intensive care
  • Preoperative non-invasive ventilation due to respiratory failure or a higher level of care than a regular ward

研究组 & 干预措施

HFNO

Experimental

Group of patients receiving HFNO postoperatively

干预措施: High Flow Oxygen (Combination Product)

Conventional oxygen therapy (COT)

Active Comparator

Group of patients receiving conventional oxygen therapy postoperatively

干预措施: Oxygen (Combination Product)

结局指标

主要结局

Frequency of postoperative pulmonary complications (PPC) the first seven days after high-risk abdominal or non-cardiac thoracic surgery in high-risk patients with high-flow nasal oxygen or conventional oxygen therapy in the immediate postoperative period

时间窗: Up to 7 days after surgery

次要结局

  • Lowest SpO2 the first 2 and 24 h after randomisation(24 hours after randomisation)
  • Desaturation (SpO2 <90%) the first 2 or 4 and under 24 hours after randomisation(First 24 hours after randomisation)
  • Lowest PaO2/FiO2 ratio during the intervention period(Maximum 4 hours after start of intervention postoperatively)
  • Subjective patient comfort (visual scale 0-10)(Maximum 4 hours after start of intervention)
  • Length of stay (LOS) in the postoperative unit(Up to 7 days after surgery)
  • Length of stay in hospital(From surgery up until 30 days after surgery)
  • Mortality in hospital(Up until 30 days after surgery)
  • 30-days mortality(30 days after surgery)
  • Healthy days at home 30 days after surgery(30 days postoperatively)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验